
Tabula Rasa Spotlight: An Inside Look with ROBO Global
In this video segment Nina Deka, Senior Research Analyst at ROBO Global, speaks with the management team at Tabula Rasa HealthCare to learn how the company is using data analytics to manage medication risk and keep people out of hospitals. Adverse drug events account for over 125,000 hospital admissions each year at a hefty cost to the healthcare system of ~$30B. The unfortunate truth is that the vast majority of these events are caused by medication errors that could have been prevented. A member of the ROBO Global HTEC Index, Tabula Rasa provides patient-specific, data-driven technology and solutions that help healthcare organizations lower costs and improve the overall health and well being of their patients.
Recent White Papers
-
Mar 8, 2021
Follow the Money: 2020 M&A Report
While M&A has been a strong tailwind since the inception of the RO...
-
Jan 13, 2021
ROBO Global Quarterly Review Q4 2020
The ROBO Global innovation indices ended 2020 with a bang, largely out...
Categories
- All
- 3D Printing
- 5G
- Additive Manufacturing
- Advisor Spotlight
- Advisory Committee
- AI
- Automation
- Automative
- Automotive
- Companion Robots
- COVID-19
- Deep Learning
- Drones
- ESG investing
- ESG policy
- Featured
- grocery
- Healthcare
- HTEC
- Investment strategy
- IOT
- life sciences
- Logistics Automation
- Machine Learning
- Machine Vision
- manufacturing
- Market Commentary
- News
- Politics
- Precision Agriculture
- ROBO
- Robo Global Index News
- Robotics
- Robotics & AI Investing
- Security
- Spotlight Article
- Supply Chain
- Technology
- Telehealth
- THNQ
- Uncategorized
- Web